Repligen Corp (RGEN)
145.65
-1.30
(-0.88%)
USD |
NASDAQ |
Dec 26, 16:00
149.06
+3.41
(+2.34%)
After-Hours: 20:00
Repligen Free Cash Flow: 131.26M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| West Pharmaceutical Services Inc | 321.60M |
| QuidelOrtho Corp | -96.80M |
| Perspective Therapeutics Inc | -40.58M |
| Xtant Medical Holdings Inc | -17.28M |
| Catheter Precision Inc | -8.381M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 49.32M |
| Cash from Investing (Quarterly) | -5.859M |
| Cash from Financing (Quarterly) | -69.60M |
| Free Cash Flow Per Share (Quarterly) | 0.7531 |
| Free Cash Flow to Equity (Quarterly) | 107.78M |
| Free Cash Flow to Firm (Quarterly) | 45.34M |
| Free Cash Flow Yield | 1.60% |